(Q35841209)

10 August 2017

The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin (English)

1 reference

10 August 2017

1 reference

1 reference

3

William V Tamborlane

1 reference

10 August 2017

1

Eda Cengiz

1 reference

10 August 2017

Karena L Swan

2

1 reference

10 August 2017

Jennifer L Sherr

series ordinal

4

1 reference

10 August 2017

Melody Martin

series ordinal

5

1 reference

10 August 2017

Stuart A Weinzimer

series ordinal

6

1 reference

10 August 2017

language of work or name

English

0 references

publication date

28 February 2012

1 reference

10 August 2017

1 reference

10 August 2017

35

1 reference

10 August 2017

4

1 reference

10 August 2017

690-692

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

10 August 2017

start time

1 September 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Mixing insulin aspart with detemir does not affect glucose excursion in children with type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308292

Early pharmacokinetic and pharmacodynamic effects of mixing lispro with glargine insulin: results of glucose clamp studies in youth with type 1 diabetes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308292

Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308292

Glucose clamp technique: a method for quantifying insulin secretion and resistance

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308292

A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308292

Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308292

A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308292

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22374642

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22374642

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mixing rapid-acting insulin analogues with insulin glargine in children with type 1 diabetes mellitus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22374642

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2337/DC11-0732

1 reference

10 August 2017

1 reference

10 August 2017

1 reference